Mangoceuticals, Inc. says it changed the rights of stockholders and created a new Series D Preferred Stock.

MGRX · Mangoceuticals, Inc.

The AI's read

Common shareholders would wait behind Series D holders for dividends and money distributed if the company closes. The amendments also waive some Series B and C protections for Series D transactions. No Series D shares were issued, so those new payment claims do not yet exist. Existing Series C dividends remain recorded, but Series D would still rank ahead of them.